First PREMIER Bank
Source: SEC Form 13F · as of Mar 2026First PREMIER Bank holds 16 biotech & pharma companies tracked by BioSniper, totaling $19K in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$19K
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 36,424 | $9K |
| AMGNAMGEN INC | 8,950 | $3K |
| MRKMerck & Co., Inc. | 22,012 | $3K |
| ABBVAbbVie Inc. | 6,749 | $1K |
| GILDGILEAD SCIENCES, INC. | 5,692 | $793 |
| ABTABBOTT LABORATORIES | 6,110 | $628 |
| LLYELI LILLY & Co | 567 | $522 |
| PFEPFIZER INC | 15,632 | $440 |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,293 | $237 |
| BMYBRISTOL MYERS SQUIBB CO | 3,103 | $188 |
| NVSNovartis AG | 500 | $76 |
| SABSSAB BIOTHERAPEUTICS, INC. | 18,986 | $73 |
| PMPhilip Morris International Inc | 100 | $17 |
| NVONovo Nordisk A/S | 100 | $4 |
| VTRSViatris Inc | 78 | $1 |
| GEHCGE HealthCare Technologies Inc. | 3 | $0 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.